(Q40934125)

25 September 2017

title

Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia (English)

1 reference

25 September 2017

1 reference

Swaminathan N

1

1 reference

25 September 2017

Lopez-Berestein G

series ordinal

2

1 reference

25 September 2017

Rudikoff S

series ordinal

3

1 reference

25 September 2017

publication date

1 July 1999

1 reference

25 September 2017

1 reference

25 September 2017

volume

16

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

119-128

1 reference

Hypercalcaemia and increased serum interleukin-6 levels induced by all-trans retinoic acid in patients with multiple myeloma

25 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02785845

21 January 2018

Plasmacytomas in mice

1 reference

12 December 2020

Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid

1 reference

12 December 2020

Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice.

1 reference

12 December 2020

Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice

1 reference

12 December 2020

Treatment of promyelocytic blast crisis of chronic myelogenous leukemia with all trans-retinoic acid.

1 reference

12 December 2020

The developmental history of the neoplastic plasma cell in mice: a brief review of recent developments

1 reference

12 December 2020

All-trans retinoic acid in combination with alpha-interferon and dexamethasone for advanced multiple myeloma.

1 reference

12 December 2020

Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia

1 reference

12 December 2020

Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.

1 reference

12 December 2020

T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors

1 reference

12 December 2020

Rapid induction of hemopoietic neoplasms in newborn mice by a raf(mil)/myc recombinant murine retrovirus

1 reference

12 December 2020

v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.

1 reference

12 December 2020

Acute promyelocytic leukemia: biology and treatment

1 reference

12 December 2020

All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study

1 reference

12 December 2020

Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6.

1 reference

12 December 2020

Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment

1 reference

12 December 2020

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

12 December 2020

Development of plasma-cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin-oil adjuvant, heart-killed Staphylococcus mixtures

1 reference

12 December 2020

All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL)

1 reference

12 December 2020

All-trans retinoic acid for advanced multiple myeloma

1 reference

12 December 2020

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results

1 reference

12 December 2020

Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis

1 reference

12 December 2020

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

1 reference

12 December 2020

Disseminated growth of murine plasmacytoma: similarities to multiple myeloma

1 reference

12 December 2020

Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: synergy through modulation of interleukin-6 autocrine loop at multiple sites.

1 reference

12 December 2020

All-trans retinoic acid in hematological malignancies, an update. GER (Gruppo Ematologico Retinoidi).

1 reference

12 December 2020

Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens

1 reference

12 December 2020

Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid

1 reference

12 December 2020

Interleukin 6 is essential for in vivo development of B lineage neoplasms

1 reference

12 December 2020

Induction of Plasma Cell Tumours in BALB/c Mice with 2,6,10,14-Tetramethylpentadecane (Pristane)

1 reference

12 December 2020

Response patterns of purified myeloma cells to hematopoietic growth factors

1 reference

12 December 2020

An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis

1 reference

12 December 2020

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

1 reference

12 December 2020

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

1 reference

12 December 2020

All-trans retinoic acid in the treatment of myelodysplastic syndromes.

1 reference

12 December 2020

Production of high-titer helper-free retroviruses by transient transfection

1 reference

12 December 2020

IL-6-receptor-mediated growth inhibition by all-trans retinoic acid but not by interferon-alpha in human myeloma cells

1 reference

12 December 2020

Retinoic acid inhibits the growth of human myeloma cells in vitro.

1 reference

12 December 2020

Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice

1 reference

12 December 2020

Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction

1 reference

12 December 2020

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

12 December 2020

Plasmacytoma development in mice injected with silicone gels

1 reference

12 December 2020

Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants

1 reference

12 December 2020

Modulation of all‐trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon‐α therapy

1 reference

12 December 2020

The requirement of an adherent cell substratum for the growth of developing plasmacytoma cells in vivo

1 reference

12 December 2020

Improved multilineage response of hematopoiesis in patients with myelodysplastic syndromes to a combination therapy with all- trans -retinoic acid, granulocyte colony-stimulating factor, erythropoietin and α-tocopherol

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02785845

1 reference

Dimensions Publication ID

25 September 2017

1022935121

0 references

1 reference